Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study
Background:
With the rapid expansion of antiretroviral therapy (ART) services in sub-Saharan Africa there is growing recognition of the importance of fertility and childbearing among HIV-infected women. However there are few data on whether ART initiation influences pregnancy rates.
Methods and Findings:
We analyzed data from the Mother-to-Child Transmission-Plus (MTCT-Plus) Initiative, a multicountry HIV care and treatment program for women, children, and families. From 11 programs in seven African countries, women were enrolled into care regardless of HIV disease stage and followed at regular intervals; ART was initiated according to national guidelines on the basis of immunological and/or clinical criteria. Standardized forms were used to collect sociodemographic and clinical data, including incident pregnancies. Overall 589 incident pregnancies were observed among the 4,531 women included in this analysis (pregnancy incidence, 7.8/100 person-years [PY]). The rate of new pregnancies was significantly higher among women receiving ART (9.0/100 PY) compared to women not on ART (6.5/100 PY) (adjusted hazard ratio, 1.74; 95% confidence interval, 1.19–2.54). Other factors independently associated with increased risk of incident pregnancy included younger age, lower educational attainment, being married or cohabiting, having a male partner enrolled into the program, failure to use nonbarrier contraception, and higher CD4 cell counts.
Conclusions:
ART use is associated with significantly higher pregnancy rates among HIV-infected women in sub-Saharan Africa. While the possible behavioral or biomedical mechanisms that may underlie this association require further investigation, these data highlight the importance of pregnancy planning and management as a critical but neglected component of HIV care and treatment services.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study. PLoS Med 7(2): e32767. doi:10.1371/journal.pmed.1000229
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000229
Souhrn
Background:
With the rapid expansion of antiretroviral therapy (ART) services in sub-Saharan Africa there is growing recognition of the importance of fertility and childbearing among HIV-infected women. However there are few data on whether ART initiation influences pregnancy rates.
Methods and Findings:
We analyzed data from the Mother-to-Child Transmission-Plus (MTCT-Plus) Initiative, a multicountry HIV care and treatment program for women, children, and families. From 11 programs in seven African countries, women were enrolled into care regardless of HIV disease stage and followed at regular intervals; ART was initiated according to national guidelines on the basis of immunological and/or clinical criteria. Standardized forms were used to collect sociodemographic and clinical data, including incident pregnancies. Overall 589 incident pregnancies were observed among the 4,531 women included in this analysis (pregnancy incidence, 7.8/100 person-years [PY]). The rate of new pregnancies was significantly higher among women receiving ART (9.0/100 PY) compared to women not on ART (6.5/100 PY) (adjusted hazard ratio, 1.74; 95% confidence interval, 1.19–2.54). Other factors independently associated with increased risk of incident pregnancy included younger age, lower educational attainment, being married or cohabiting, having a male partner enrolled into the program, failure to use nonbarrier contraception, and higher CD4 cell counts.
Conclusions:
ART use is associated with significantly higher pregnancy rates among HIV-infected women in sub-Saharan Africa. While the possible behavioral or biomedical mechanisms that may underlie this association require further investigation, these data highlight the importance of pregnancy planning and management as a critical but neglected component of HIV care and treatment services.
: Please see later in the article for the Editors' Summary
Zdroje
1. World Health Organization, UNAIDS, UNICEF 2008 Towards Universal access: Scaling up priority HIV/AIDS interventions in the health sector: progress report: 2008 Geneva World Health Organization
2. GruskinS
FergusonL
O'MalleyJ
2007 Ensuring sexual and reproductive health for people living with HIV: an overview of key human rights, policy and health systems issues. Reprod Health Matters 15 4 26
3. MyerL
MorroniC
El-SadrWM
2005 Reproductive decisions in HIV-infected individuals. Lancet 366 698 700
4. AbramsEJ
MyerL
RosenfieldA
El-SadrWM
2007 Prevention of mother-to-child transmission services as a gateway to family-based human immunodeficiency virus care and treatment in resource-limited settings: rationale and international experiences. Am J Obstet Gynecol 197 S101 S106
5. MassadLS
SpringerG
JacobsonL
WattsH
AnastosK
2004 Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV. AIDS 18 281 286
6. FioreS
HeardI
ThorneC
SavasiV
CollO
2008 Reproductive experience of HIV-infected women living in Europe. Hum Reprod 23 2140 2144
7. ChenJL
PhilipsKA
KanouseDE
CollinsRL
MiuA
2001 Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 33 144 152, 165
8. DyerSJ
2007 The value of children in African countries: insights from studies on infertility. J Psychosom Obstet Gynaecol 28 69 77
9. CooperD
HarriesJ
MyerL
OrnerP
BrackenH
2007 “Life is still going on”: reproductive intentions among HIV-positive women and men in South Africa. Soc Sci Med 65 274 283
10. AllenS
SerufiliraA
GruberV
KegelesS
Van de PerreP
1993 Pregnancy and contraception use among urban Rwandan women after HIV testing and counseling. Am J Public Health 83 705 710
11. MaierM
AndiaI
EmenyonuN
GuzmanD
KaidaA
2008 Antiretroviral therapy is associated with increased fertility desire, but not pregnancy or live birth, among HIV+ women in an early HIV treatment program in rural Uganda. AIDS Behav 13 28 37
12. MyerL
RebeK
MorroniC
2007 Missed opportunities to address reproductive health care needs among HIV-infected women in antiretroviral therapy programmes. Trop Med Int Health 12 1484 1489
13. SweatMD
O'ReillyKR
SchmidGP
DenisonJ
de ZoysaI
2004 Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 18 1661 1671
14. BussmannH
WesterCW
WesterCN
LekokoB
OkezieO
2007 Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. J Acquir Immune Defic Syndr 45 269 273
15. El-IbiarySY
CocohobaJM
2008 Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Eur J Contracept Reprod Health Care 13 123 132
16. MyerL
RabkinM
AbramsEJ
RosenfieldA
El-SadrWM
2005 Focus on women: linking HIV care and treatment with reproductive health services in the MTCT-Plus Initiative. Reprod Health Matters 13 136 146
17. RabkinM
El-SadrWM
2003 Saving mothers, saving families: the MTCT-Plus Initiative. WHO Perspectives and practice in antiretroviral treatment Geneva World Health Organization
18. World Health Organization 2003 Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach Geneva World Health Organization
19. WhiteH
1980 A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskdasticity. Econometrica 48 817 830
20. KaidaA
GrayG
BastosFI
AndiaI
MaierM
2008 The relationship between HAART use and sexual activity among HIV-positive women of reproductive age in Brazil, South Africa, and Uganda. AIDS Care 20 21 25
21. KaidaA
AndiaI
MaierM
StrathdeeSA
BangsbergDR
2006 The potential impact of antiretroviral therapy on fertility in sub-Saharan Africa. Curr HIV/AIDS Rep 3 187 194
22. RossA
Van der PaalL
LubegaR
MayanjaBN
ShaferLA
2004 HIV-1 disease progression and fertility: the incidence of recognized pregnancy and pregnancy outcome in Uganda. Aids 18 799 804
23. SedghG
LarsenU
SpiegelmanD
MsamangaG
FawziWW
2005 HIV-1 disease progression and fertility in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 39 439 445
24. HubacherD
MavranezouliI
McGinnE
2008 Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it. Contraception 78 73 78
25. ClelandJ
BernsteinS
EzehA
FaundesA
GlasierA
2006 Family planning: the unfinished agenda. Lancet 368 1810 1827
26. TauloF
BerryM
TsuiA
MakananiB
KafulafulaG
2009 Fertility intentions of HIV-1 infected and uninfected women in Malawi: a longitudinal study. AIDS Behav 13 Suppl 1 20 27
27. HomsyJ
BunnellR
MooreD
KingR
MalambaS
2009 Reproductive intentions and outcomes among women on antiretroviral therapy in rural Uganda: a prospective cohort study. PLoS One 4 e4149 doi:10.1371/journal.pone.0004149
28. MyerL
MorroniC
RebeK
2007 Prevalence and determinants of fertility intentions of HIV-infected women and men receiving antiretroviral therapy in South Africa. AIDS Patient Care STDS 21 278 285
29. PaivaV
FilipeEV
SantosN
LimaTN
SeguradoA
2003 The right to love: the desire for parenthood among men living with HIV. Reprod Health Matters 11 91 100
30. PaivaV
SantosN
Franca-JuniorI
FilipeE
AyresJR
2007 Desire to have children: gender and reproductive rights of men and women living with HIV: a challenge to health care in Brazil. AIDS Patient Care STDS 21 268 277
31. World Health Organization 2004 Medical eligibility for contraceptive use. Third edition Geneva WHO
32. MildvanD
YarrishR
MarshakA
HutmanHW
McDonoughM
2002 Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. J Acquir Immune Defic Syndr 29 471 477
33. RyderRW
KamengaC
JinguM
MbuyiN
MbuL
2000 Pregnancy and HIV-1 incidence in 178 married couples with discordant HIV-1 serostatus: additional experience at an HIV-1 counselling centre in the Democratic Republic of the Congo. Trop Med Int Health 5 482 487
34. GrayRH
WawerMJ
SerwaddaD
SewankamboN
LiC
1998 Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 351 98 103
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 2
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
- Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
- Developing Global Maps of the Dominant Vectors of Human Malaria
- Guidance for Developers of Health Research Reporting Guidelines